Cytomaite II – Uncovering Prognostic Biomarkers in Leukemia with Explainable AI
Artificial intelligence and machine learning in hematology. From the AI-supported data pipeline to prediction
Extracellular matrix mediated immune invasion in glioblastoma
ai4CryoCAR: AI assisted assessment of cryopreserved CAR immune cell functionality against leukemia
AI-Sign: Artificial Intelligence Enabled Signature Detection in Multi-Analyte Liquid Biopsy Data
Microscopy based evaluation of drug response profiles in NPM1c acute myeloid leukemia
Artificial intelligence and machine learning in hematology. From the AI-supported data pipeline to prediction
Part A: Advancing Cancer Research through Innovative Image Analysis Tools
Observational, prospective pilot study on affect and stress detection and modeling throughout the patient pathway in oncology
Cytomaite Development of artificial intelligence-driven tools based on cytomorphological analysis for diagnostic and outcome prediction of patients with acute hematological diseases
Funded By Mertelsmann Foundation
The Mertelsmann Foundation has made improving the fight against cancer with the help of innovative methods its main concern. To this end, it brings together cancer research and artificial intelligence. In doing so, it relies on interdisciplinary collaboration between experimental and clinical oncology, artificial intelligence and philosophy.